Go Pro

Zevra Therapeutics (ZVRA) Institutional Ownership

Zevra Therapeutics logo
$11.87 -0.02 (-0.17%)
As of 08/21/2026 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Zevra Therapeutics (NASDAQ:ZVRA)

Current
Institutional Ownership
Percentage
35.03%
Number of
Institutional Buyers
(last 12 months)
73
Total
Institutional Inflows
(last 12 months)
$100.40M
Number of
Institutional Sellers
(last 12 months)
35
Total
Institutional Outflows
(last 12 months)
$42.98M
Get ZVRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Zevra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ZVRA Institutional Buying and Selling by Quarter

Zevra Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/19/2026 Wellington Management Group LLP164,538$2.36M0.0%+5.2%0.277%
8/13/2026 Globeflex Capital L P191,904$2.75M0.4%N/A0.323%
8/6/2026 Bank of New York Mellon Corp198,432$2.85M0.0%N/A0.336%
7/9/2026 Hennion & Walsh Asset Management Inc.383,706$5.50M0.2%+116.6%0.649%
5/20/2026 Arete Wealth Advisors LLC66,397$617K0.0%-4.8%0.112%
5/19/2026 Bank of America Corp DE64,837$604K0.0%-55.7%0.110%
5/19/2026 Arete Wealth Advisors LLC66,397$617K0.0%-4.8%0.112%
5/16/2026 The Manufacturers Life Insurance Company15,137$141K0.0%-10.4%0.026%
5/16/2026 Quantinno Capital Management LP32,022$298K0.0%+114.1%0.054%
5/7/2026 Dimensional Fund Advisors LP554,802$5.17M0.0%+259.2%0.938%
5/5/2026 Bank of New York Mellon Corp172,427$1.61M0.0%-1.0%0.292%
5/5/2026 Sanctuary Advisors LLC18,490$172K0.0%-46.3%0.031%
4/30/2026 AIGH Capital Management LLC1,200,000$11.18M1.5%N/A2.030%
4/27/2026 Simplify Asset Management Inc.100,630$938K0.0%+137.5%0.170%
4/22/2026 Janney Montgomery Scott LLC236,834$2.21M0.0%+16.7%0.403%
3/5/2026 Gunpowder Capital Management LLC dba Oliver Wealth Management5,891$53K0.0%N/A0.010%
2/24/2026DGS Capital Management LLC14,810$133K0.0%N/A0.026%
2/18/2026 NewEdge Advisors LLC4,000$36K0.0%-82.1%0.007%
2/18/2026 Wellington Management Group LLP170,309$1.53M0.0%-9.1%0.303%
2/18/2026 Polymer Capital Management US LLC17,123$153K0.0%-46.0%0.030%
2/18/2026 Millennium Management LLC1,134,358$10.16M0.0%+9.6%2.015%
2/18/2026 Man Group plc92,347$827K0.0%+174.4%0.164%
2/18/2026 Engineers Gate Manager LP44,020$394K0.0%+23.4%0.078%
2/18/2026 683 Capital Management LLC905,000$8.11M0.4%-7.2%1.607%
2/17/2026 Schonfeld Strategic Advisors LLC13,824$124K0.0%N/A0.025%
2/17/2026 AQR Capital Management LLC181,129$1.62M0.0%+18.9%0.322%
2/17/2026 Trexquant Investment LP209,704$1.88M0.0%-30.8%0.372%
2/17/2026 Price T Rowe Associates Inc. MD32,140$288K0.0%+12.8%0.057%
2/17/2026 Adage Capital Partners GP L.L.C.275,000$2.46M0.0%-87.6%0.488%
2/17/2026 Royal Bank of Canada4,582$42K0.0%-52.7%0.008%
2/17/2026 Carret Asset Management LLC54,000$484K0.0%-5.3%0.096%
2/16/2026 Squarepoint Ops LLC317,066$2.84M0.0%+18.3%0.563%
2/16/2026 Verition Fund Management LLC17,704$159K0.0%-90.9%0.031%
2/16/2026 Barclays PLC100,135$897K0.0%-69.9%0.178%
2/13/2026 Arete Wealth Advisors LLC69,769$625K0.0%-6.1%0.124%
2/13/2026 Nantahala Capital Management LLC1,771,936$15.88M0.5%-10.1%3.147%
2/13/2026 Marshall Wace LLP669,742$6.00M0.0%-26.6%1.190%
2/13/2026 The Manufacturers Life Insurance Company 16,896$151K0.0%-9.5%0.030%
2/13/2026 Schroder Investment Management Group506,033$4.46M0.0%+22.7%0.899%
2/13/2026 Rafferty Asset Management LLC15,920$143K0.0%+34.0%0.028%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
2/13/2026 Charles Schwab Investment Management Inc.180,618$1.62M0.0%+14.5%0.321%
2/13/2026 State Street Corp1,482,956$13.29M0.0%+3.9%2.634%
2/13/2026 Wells Fargo & Company MN66,950$600K0.0%+81.7%0.119%
2/12/2026 MetLife Investment Management LLC27,867$250K0.0%+10.5%0.049%
2/12/2026 Commonwealth Equity Services LLC14,229$127K0.0%-45.2%0.025%
2/12/2026 Dimensional Fund Advisors LP154,466$1.38M0.0%N/A0.274%
2/12/2026 EntryPoint Capital LLC52,871$474K0.2%+83.1%0.094%
2/12/2026 Integrated Quantitative Investments LLC56,128$503K0.1%N/A0.100%
2/12/2026 Federated Hermes Inc.23,453$210K0.0%+17.8%0.042%
2/12/2026 Nuveen LLC143,132$1.28M0.0%-6.5%0.254%
2/11/2026 Janney Montgomery Scott LLC202,883$1.82M0.0%+10.4%0.360%
2/11/2026 Deutsche Bank AG45,939$412K0.0%+4.4%0.082%
2/11/2026 Fox Run Management L.L.C.24,722$222K0.0%-20.3%0.044%
2/11/2026 JPMorgan Chase & Co.412,261$3.69M0.0%-6.1%0.732%
2/11/2026 Los Angeles Capital Management LLC54,454$488K0.0%-7.0%0.097%
2/11/2026 Propel Bio Management LLC63,683$571K0.5%-72.5%0.113%
2/11/2026 WINTON GROUP Ltd26,089$234K0.0%+114.5%0.046%
2/10/2026 Northwestern Mutual Wealth Management Co.15,000$134K0.0%N/A0.027%
2/9/2026 Geode Capital Management LLC1,341,681$12.03M0.0%+3.2%2.383%
2/9/2026 Royce & Associates LP865,822$7.76M0.1%+25.3%1.538%
2/9/2026 Legal & General Group Plc1,097,988$9.84M0.0%+4.2%1.950%
2/9/2026 Simplify Asset Management Inc.42,365$380K0.0%-71.2%0.075%
2/9/2026Jefferies Financial Group Inc.120,000$1.08M0.0%N/A0.213%
2/6/2026 ProShare Advisors LLC12,669$114K0.0%+12.3%0.023%
2/4/2026 Bailard Inc.12,900$116K0.0%N/A0.023%
1/29/2026 UBS Group AG285,488$2.56M0.0%+30.9%0.507%
1/29/2026 Sanctuary Advisors LLC34,461$309K0.0%+18.0%0.061%
1/28/2026 Retirement Planning Co of New England Inc.662,976$5.94M2.4%+10.4%1.178%
1/20/2026 Stratos Wealth Partners LTD.409,000$3.67M0.0%+78.6%0.726%
1/14/2026 Hennion & Walsh Asset Management Inc.139,591$1.25M0.0%N/A0.248%
1/9/2026 SG Americas Securities LLC13,543$121K0.0%N/A0.024%
1/1/2026 JPMorgan Chase & Co.438,984$4.18M0.0%+1,458.8%0.780%
12/1/2025 Cantor Fitzgerald L. P.117,576$1.12M0.0%+487.9%0.209%
11/17/2025 NewEdge Advisors LLC22,338$212K0.0%+458.5%0.040%
11/17/2025 Caxton Associates LLP17,317$165K0.0%N/A0.031%
11/17/2025 Woodline Partners LP3,476,143$33.06M0.2%-24.7%6.175%
11/17/2025 PharVision Advisers LLC66,733$635K0.4%N/A0.119%
11/17/2025 XTX Topco Ltd66,381$631K0.0%N/A0.118%
11/17/2025 Verition Fund Management LLC193,509$1.84M0.0%N/A0.344%
11/17/2025 Polymer Capital Management US LLC31,698$301K0.0%+89.4%0.056%
11/17/2025 Quarry LP10,883$103K0.0%N/A0.019%
11/17/2025 Qube Research & Technologies Ltd306,489$2.92M0.0%+2,615.2%0.544%
11/17/2025 Prelude Capital Management LLC15,600$148K0.0%N/A0.028%
11/17/2025 Nantahala Capital Management LLC1,971,936$18.75M0.7%+34.0%3.503%
11/17/2025 Millennium Management LLC1,035,251$9.85M0.0%+63.1%1.839%
11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.24,896$237K0.0%-17.7%0.044%
11/17/2025 Integrated Wealth Concepts LLC15,081$143K0.0%N/A0.027%
11/17/2025 Kingdon Capital Management L.L.C.650,000$6.18M0.8%+44.4%1.155%
11/17/2025 Brevan Howard Capital Management LP130,751$1.24M0.0%N/A0.232%
11/17/2025 Cantor Fitzgerald L. P.117,576$1.12M0.0%+487.9%0.209%
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)

We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel

👉 Unlock the ticker now and get it completely free.
11/17/2025 Bank of America Corp DE288,045$2.74M0.0%+28.7%0.512%
11/17/2025 Boothbay Fund Management LLC14,943$142K0.0%N/A0.027%
11/17/2025 Aquatic Capital Management LLC28,593$272K0.0%-11.5%0.051%
11/17/2025 Algert Global LLC418,550$3.98M0.1%N/A0.743%
11/14/2025 Raymond James Financial Inc.23,306$222K0.0%-13.4%0.041%
11/14/2025 Virtu Financial LLC62,740$597K0.0%N/A0.111%
11/14/2025 Man Group plc33,652$320K0.0%N/A0.060%
11/14/2025 Squarepoint Ops LLC268,077$2.55M0.0%N/A0.476%
11/13/2025 Marshall Wace LLP912,299$8.68M0.0%N/A1.620%
11/13/2025 UBS Group AG218,096$2.07M0.0%+41.5%0.387%


ZVRA Institutional Ownership - Frequently Asked Questions

During the previous two years, 121 institutional investors and hedge funds held shares of Zevra Therapeutics. The most heavily invested institutionals were Woodline Partners LP ($33.06M), Vanguard Group Inc. ($29.32M), Rubric Capital Management LP ($17.25M), FMR LLC ($16.05M), Nantahala Capital Management LLC ($15.88M), State Street Corp ($13.29M), and Geode Capital Management LLC ($12.03M).Learn more on Zevra Therapeutics' institutional investors.

35.03% of Zevra Therapeutics' stock is owned by institutional investors. Learn more on ZVRA's institutional investor holdings.

Of the 111 institutional investors that purchased Zevra Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Adage Capital Partners GP L.L.C. ($3.55M), AIGH Capital Management LLC ($2.64M), FMR LLC ($2.31M), Marshall Wace LLP ($912.30K), Stonepine Capital Management LLC ($877.92K), Royce & Associates LP ($865.82K), and JPMorgan Chase & Co. ($830.87K).

Institutional investors have bought a total of 10,379,505 shares in the last 24 months. This purchase volume represents approximately $100.40M in transactions.

Of the 35 institutional investors that sold Zevra Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($1.95M), Woodline Partners LP ($1.14M), Marshall Wace LLP ($242.56K), Barclays PLC ($232.31K), Nantahala Capital Management LLC ($200K), Verition Fund Management LLC ($175.81K), and Propel Bio Management LLC ($168.19K).

Institutional investors have sold a total of 4,716,001 shares in the last 24 months. This volume of shares sold represents approximately $42.98M in transactions.



Institutional ownership data for NASDAQ:ZVRA is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/19/2026. New 13F filings are added each quarter as they're published.
From Our Partners